News
August 7, 2019
Cure SMA Releases Status Update on Data Accuracy Issues with Zolgensma
Yesterday, the FDA issued a statement identifying data accuracy issues with Avexis’ SMA therapy, Zolgensma. Cure SMA is in communication with the FDA and is committed to representing the SMA patient voice and...
Topics: Front Page News
August 6, 2019
FDA Issues Statement on Data Accuracy Issues with Recently Approved Gene Therapy
Today, the FDA issued the below statement identifying data accuracy issues with AveXis’ SMA therapy, Zolgensma. Cure SMA is investigating this issue and will report when we have further details. We will be...
Topics: Front Page News
August 5, 2019
Biogen Issues Community Statement on Spinraza
Biogen has provided the following community statement on Spinraza.
Dear members of the SMA community,
Following a busy spring of data presentations at medical congresses and the annual Cure SMA Conference, we are pleased to provide updates on research highlighting...
Topics: Clinical Trials, Research, Front Page News
July 31, 2019
SMA Awareness Month 2019 Has Begun!
The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month and Cure SMA has been coordinating activities since 1996. August is a great time to spotlight the work our community does year-round to raise awareness of and funds for SMA.
In addition to our...
Topics: Community & Awareness, Front Page News
July 24, 2019
Cure SMA Welcomes the New North Florida and Oklahoma Chapters
Cure SMA is pleased to announce the creation of two new chapters: North Florida and Oklahoma. The chapters are eager to begin helping families throughout these areas and fundraising to support research to find a cure for SMA.
The Oklahoma Chapter will be led by chairpersons Amanda...
Topics: Community & Awareness, Events & Fundraising, Front Page News
July 1, 2019
Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference
Biogen today announced new results from the NURTURE study, adding data to the longest study of spinal muscular atrophy (SMA) in pre-symptomatic...
Topics: Clinical Trials, Research, Front Page News
June 28, 2019
Updated SMA Drug Pipeline Now Available
We’ve recently released an update to the SMA drug pipeline. This latest version includes:
- 23 active programs, including two approved therapies.
- 15 pharmaceutical partners.
- 6 programs in clinical trials.
- An ever-increasing breadth of potential...
Topics: Our Impact, Research, Front Page News
June 28, 2019
Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference
Cytokinetics, Incorporated, today announced that data from two preclinical studies of reldesemtiv were presented at the 2019 Annual Cure SMA...
Topics: Clinical Trials, Research, Front Page News
June 26, 2019
What People Are Saying: 2019 North Jersey Walk-n-Roll
The North Jersey Cure SMA Chapter held their 4th annual North Jersey Walk-n-Roll on June 22, 2019 at the Roosevelt Park. Walk-n-Roll is a...
Topics: Community & Awareness, Events & Fundraising, Front Page News
June 26, 2019
The 2019 Annual SMA Conference is Here!
The 2019 Annual SMA Conference, now in its 31st year, is set to kick off on June 28 and continue into a weekend full of programs and events that bring families, researchers and healthcare professionals...
Topics: Conference, Front Page News